CIK 0001665988
- Accelerated filer
- Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810980861
- Phone
- +1 919-474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Planned sale SVP & Chief Compliance Officer sold 2,535 shares at $10.53 ($26,694)
- 4 Planned sale SVP & General Counsel sold 5,848 shares at $10.53 ($61,579)
- 4 Exercise or conversion SVP & CFO acquired 31,000 shares (option exercise)
- 4 Exercise or conversion SVP & Chief Compliance Officer acquired 8,600 shares (option exercise)
- 4 Exercise or conversion SVP & General Counsel acquired 19,850 shares (option exercise)
- 4 Open-market buy Director bought 105,500 shares at an average $8.55 ($901,702)
- 4 Planned sale SVP & CFO sold 9,219 shares at $5.57 ($51,350)
- 4 Planned sale SVP & General Counsel sold 5,904 shares at $5.57 ($32,885)
- 4 Planned sale SVP & Chief Compliance Officer sold 2,559 shares at $5.57 ($14,254)
- 4 Exercise or conversion SVP & CFO acquired 31,000 shares (option exercise)
- 4 Exercise or conversion SVP & General Counsel acquired 19,850 shares (option exercise)
- 4 Exercise or conversion SVP & Chief Compliance Officer acquired 8,600 shares (option exercise)
- 4 Planned sale SVP & CFO sold 13,753 shares at $5.84 ($80,318)
- 4 Planned sale SVP & General Counsel sold 11,308 shares at $5.84 ($66,039)
- 4 Planned sale SVP & Chief Compliance Officer sold 8,759 shares at $5.84 ($51,153)
- 4 Exercise or conversion Director acquired 386 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,814 shares (option exercise)
- 4 Exercise or conversion Director acquired 965 shares (option exercise)
- 4 Exercise or conversion SVP & CFO acquired 42,202 shares (option exercise)
- 4 Exercise or conversion SVP & General Counsel acquired 34,696 shares (option exercise)
Page 4 of 13 · 251 filings